104 related articles for article (PubMed ID: 2930684)
1. Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor.
Matthews N; Neale ML
Br J Cancer; 1989 Feb; 59(2):189-93. PubMed ID: 2930684
[TBL] [Abstract][Full Text] [Related]
2. Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs.
Neale ML; Matthews N
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):133-7. PubMed ID: 2493381
[TBL] [Abstract][Full Text] [Related]
3. Colonial morphology of tumour cells and susceptibility to cytolysis by tumour necrosis factor. The role of cellular fibronectin deposition in the extracellular matrix.
Neale ML; Matthews N
Br J Cancer; 1990 Jun; 61(6):831-5. PubMed ID: 2372484
[TBL] [Abstract][Full Text] [Related]
4. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
Fletcher WH; Shiu WW; Ishida TA; Haviland DL; Ware CF
J Immunol; 1987 Aug; 139(3):956-62. PubMed ID: 3110292
[TBL] [Abstract][Full Text] [Related]
5. Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize.
Neale ML; Fiera RA; Matthews N
Int J Cancer; 1990 Jan; 45(1):203-8. PubMed ID: 2153637
[TBL] [Abstract][Full Text] [Related]
6. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor.
Neale ML; Fiera RA; Matthews N
Immunology; 1988 May; 64(1):81-5. PubMed ID: 3133309
[TBL] [Abstract][Full Text] [Related]
7. Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts.
Pizzo P; Murgia M; Zambon A; Zanovello P; Bronte V; Pietrobon D; Di Virgilio F
J Immunol; 1992 Nov; 149(10):3372-8. PubMed ID: 1431111
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic and necrotic effects of tumour necrosis factor-alpha potentiated with hyperthermia on L929 and tumour necrosis factor-alpha-resistant L929.
Lui PC; Fan YS; Xu G; Ngai CY; Fung KP; Tse GM; Yu AM; Li JY
Int J Hyperthermia; 2010; 26(6):556-64. PubMed ID: 20707650
[TBL] [Abstract][Full Text] [Related]
9. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism.
Matthews N; Neale ML; Jackson SK; Stark JM
Immunology; 1987 Sep; 62(1):153-5. PubMed ID: 3653925
[TBL] [Abstract][Full Text] [Related]
10. Step-down heating enhances the cytotoxicity of human tumour necrosis factor on murine and human tumour cell lines in vitro.
Klostergaard J; Akimaru Y; Tomasovic SP
Int J Hyperthermia; 1996; 12(1):97-114. PubMed ID: 8676012
[TBL] [Abstract][Full Text] [Related]
11. Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.
Wright SC; Tam AW; Kumar P
Cancer Immunol Immunother; 1992; 34(6):399-406. PubMed ID: 1563018
[TBL] [Abstract][Full Text] [Related]
12. TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity.
Polla BS; Jacquier-Sarlin MR; Kantengwa S; Mariéthoz E; Hennet T; Russo-Marie F; Cossarizza A
Free Radic Res; 1996 Aug; 25(2):125-31. PubMed ID: 8885330
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and resistance to hydrogen peroxide confer resistance to tumor necrosis factor in murine L929 cells.
Park YM; Anderson RL; Spitz DR; Hahn GM
Radiat Res; 1992 Aug; 131(2):162-8. PubMed ID: 1641471
[TBL] [Abstract][Full Text] [Related]
14. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
Liddil JD; Dorr RT; Scuderi P
Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic manifestations of the interaction between hyperthermia and TNF: DNA fragmentation.
Tomasovic SP; Vasey TA; Story MD; Stephens LC; Klostergaard J
Int J Hyperthermia; 1994; 10(2):247-62. PubMed ID: 8064183
[TBL] [Abstract][Full Text] [Related]
16. Complement subcomponent C1q modulation of TNF-alpha binding to L929 cells for enhanced TNF-mediated cytotoxicity.
Jiang H; Zhou A; Herriott MJ; Rummage JA; Stewart CA; Fast DJ; Leu RW
Scand J Immunol; 1996 Aug; 44(2):101-7. PubMed ID: 8711421
[TBL] [Abstract][Full Text] [Related]
17. Reversal of TNF-alpha resistance by hyperthermia: role of mitochondria.
Ko S; Yuen WF; Fung KP; Lee CY; Choy YM; Cheng HK; Kwok TT; Kong SK
Life Sci; 2000 Nov; 67(25):3113-21. PubMed ID: 11125848
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic processes induced by TNF in L929 and K562 differ in DNA fragmentation mechanisms.
Mirkina II; Mernenko OA; Satpaev DK; Karelin AA; Blishchenko EYu
Immunol Lett; 1996 Sep; 52(2-3):105-8. PubMed ID: 8905404
[TBL] [Abstract][Full Text] [Related]
19. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
Zimmerman RJ; Chan A; Leadon SA
Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
[TBL] [Abstract][Full Text] [Related]
20. Caffeine potentiates the lethality of tumour necrosis factor in cancer cells.
Belizario JE; Tilly JL; Sherwood SW
Br J Cancer; 1993 Jun; 67(6):1229-35. PubMed ID: 8512808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
